Adrenal atrophy primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenal atrophy}} | {{Adrenal atrophy}} | ||
{{CMG}}; {{AE}} {{MHP}} | |||
==Overview== | |||
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs. | |||
==Primary prevention== | |||
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs. | Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs. | ||
==References== | ==References== | ||
Revision as of 02:33, 5 February 2022
|
Adrenal atrophy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Adrenal atrophy primary prevention On the Web |
|
American Roentgen Ray Society Images of Adrenal atrophy primary prevention |
|
Risk calculators and risk factors for Adrenal atrophy primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]
Overview
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.
Primary prevention
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.